UPDATE 1-Drug pricing review group signs deal with Aetion for patient data
The Institute for Clinical and
Economic Review (ICER), a small but influential Boston-based
research group, has signed a deal with private technology
company Aetion to help it use patient health data in its reports
on whether individual drugs are priced properly.
Economic Review (ICER), a small but influential Boston-based
research group, has signed a deal with private technology
company Aetion to help it use patient health data in its reports
on whether individual drugs are priced properly.
Posted by Reuters
